| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 400.17M | 257.99M | 259.14M | 204.34M | 151.83M |
| Gross Profit | 8.27M | 30.23M | 46.31M | 39.84M | 19.51M |
| EBITDA | -36.07M | 4.57M | 25.32M | 12.35M | 3.54M |
| Net Income | -51.36M | 8.28M | 12.66M | 4.26M | 21.12M |
Balance Sheet | |||||
| Total Assets | 399.78M | 352.85M | 341.27M | 272.35M | 276.54M |
| Cash, Cash Equivalents and Short-Term Investments | 31.38M | 32.07M | 66.03M | 56.56M | 91.30M |
| Total Debt | 155.79M | 73.82M | 65.39M | 23.07M | 31.91M |
| Total Liabilities | 281.46M | 183.17M | 179.87M | 123.61M | 132.07M |
| Stockholders Equity | 118.32M | 169.68M | 161.40M | 148.74M | 144.47M |
Cash Flow | |||||
| Free Cash Flow | -64.64M | -16.67M | -25.84M | -7.36M | 81.41M |
| Operating Cash Flow | -63.83M | -5.27M | -20.50M | -2.90M | 81.62M |
| Investing Cash Flow | -10.29M | -32.36M | -8.85M | -13.05M | -73.20M |
| Financing Cash Flow | 73.44M | 3.68M | 38.82M | -18.80M | 28.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | HK$167.84M | 2.34 | -7.26% | ― | -1.91% | 18.30% | |
52 Neutral | HK$172.52M | -99.46 | -0.14% | 5.26% | -15.53% | -105.86% | |
46 Neutral | HK$182.40M | -0.77 | -48.75% | ― | 54.20% | -833.33% | |
45 Neutral | HK$101.35M | -1.28 | -47.12% | ― | -70.99% | -2960.61% | |
41 Neutral | HK$195.58M | -4.56 | -84.47% | ― | -63.83% | 36.13% | |
38 Underperform | HK$156.00M | -0.58 | -98.05% | ― | 15.26% | 10.41% |